Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

News

Sygnature gains ISO:27001 certification for information security

READ ARTICLE

News

Sygnature appoints Dr David Lustig to spearhead US expansion

READ ARTICLE

Drug Discovery News

Sygnature Discovery expands US presence with Bay Area office

READ ARTICLE

News

Freak chemistry accident turns Sygnature’s Senior VP – Alliance Management into legendary werewolf

READ ARTICLE

DMPK in vivo pharmacology News

Three of UK’s top drug discovery CROs join forces under the name Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park

READ ARTICLE

Blog Events News

Sygnature & Altasciences join forces for new webinar series

READ ARTICLE

Awards News

Sygnature Discovery named Company of the Year at Bionow Annual Awards

READ ARTICLE

Computational Sciences Drug Discovery News

Sygnature Discovery Adopts OpenEye’s Orion™ Platform to Strengthen Molecular Design Services

READ ARTICLE

Awards News

Sygnature Discovery shortlisted for BioNow Company of the Year Award

READ ARTICLE

Bioscience News

Sygnature upgrades western blotting capability with Jess instrument from Protein Simple

READ ARTICLE

News

Dr Paul Overton becomes Chief Commercial Officer (CCO) at Sygnature

READ ARTICLE
MORE...